SEARCH

SEARCH BY CITATION

References

  • 1
    Chiappini E, Bonsignori F, Accetta G et al. Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review. Int J Immunopathol Pharmacol 2012; 25: 335343.
  • 2
    Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 2010; 59: 125.
  • 3
    European Center for Disease Prevention and Control. Use of interferon gamma release in support of TB diagnosis. Available at: http://ecdc.europa.eu/en/publications/Publications/1103_GUI_IGRA.pdf (last accessed 16 May 2011).
  • 4
    Canadian Tuberculosis Committee. Recommendations on interferon gamma release assays for the diagnosis of latent tuberculosis infection—2010 update. Can Commun Dis Rep. 36, 122.
  • 5
    Tuberculose et test de détection de l’interféron gamma. Rapport du groupe de travail 1 Juillet 2011. Haut Conseil de la Santé Publique, editor. Available at: http://www.hcsp.fr/docspdf/avisrapports/hcspr20110701_interferongamma.pdf (last accessed 1 July 2011).
  • 6
    Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institute for Health and Clinical Excellence, editor. Available at: http://www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf (last accessed 22 September 2012).
  • 7
    Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010; 1: CD000171.
  • 8
    Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000; 2: CD001363.
  • 9
    Brouqui P, Salvo E, Dumler JS, Raoult D. Diagnosis of granulocytic ehrlichiosis in humans by immunofluorescence assay. Clin Diagn Lab Immunol 2001; 8: 199202.
  • 10
    Torres CJ, Silva R, Ringshausen FC, Nienhaus A. Screening for tuberculosis and prediction of disease in Portuguese healthcare workers. J Occup Med Toxicol 2011; 6: 19.
  • 11
    Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008; 177: 11641170.
  • 12
    Rangaka MX, Wilkinson KA, Glynn JR et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 4555.